⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Kindeva Drug Delivery and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Kindeva Drug Delivery
↗Woodbury, MN, United States
Kindeva Drug Delivery is a global contract development and manufacturing organization (CDMO) that specializes in complex drug-device combination products. The company provides integrated services ranging from early-stage formulation and analytical development to commercial-scale, GMP-compliant manufacturing for pharmaceutical and biotechnology clients.
With a legacy dating back to 3M Drug Delivery Systems, Kindeva focuses on specialized delivery technologies, including pulmonary, nasal, injectable, transdermal, and microneedle platforms. The company operates a global network of manufacturing and R&D facilities, supporting clients through the entire product lifecycle, including regulatory strategy and supply chain management.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Investors:Altaris Capital Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO)
Modalities:Inhalation, Injectable, Transdermal, Microneedle
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Summit Biosciences
Key Partnerships:International Pharmaceuticals Aerosol Consortium (IPAC)
COMPETITION
Position:Leader
Competitors:Societal CDMO, Agno Pharmaceuticals, Enteris BioPharma
LEADERSHIP
Key Executives:
David Stevens - CEO
Mike Cowhig - Chief Legal Officer
Daniel J. Speciale - Chief Financial Officer
LINKS
Website:kindevadd.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Kindeva Drug Delivery. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.